BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 7004326)

  • 21. Anticancer effect of sirolimus in renal allograft recipients with de novo malignancies.
    Boratyńska M; Watorek E; Smolska D; Patrzałek D; Klinger M
    Transplant Proc; 2007 Nov; 39(9):2736-9. PubMed ID: 18021973
    [TBL] [Abstract][Full Text] [Related]  

  • 22. De novo malignancies after kidney transplantation.
    Hung YM; Chou KJ; Hung SY; Chung HM; Chang JC
    Urology; 2007 Jun; 69(6):1041-4. PubMed ID: 17572182
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Incidence and clinical course of de-novo malignancies in renal allograft recipients.
    Winkelhorst JT; Brokelman WJ; Tiggeler RG; Wobbes T
    Eur J Surg Oncol; 2001 Jun; 27(4):409-13. PubMed ID: 11417989
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Diffuse lymphoproliferative disease after renal transplantation and its relation with Epstein-Barr virus. Experience at one center].
    Franco A; Jiménez L; Aranda I; Alvarez L; González M; Rocamora N; Olivares J
    Nefrologia; 2002; 22(5):463-9. PubMed ID: 12497748
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Outcome of renal transplantation in children with pericardiopleural effusion.
    Chen Y; Yen TH; Liu KL; Chiang YJ; Wu CT; Chen HW; Chu SH
    Transplant Proc; 2004 Sep; 36(7):2032-3. PubMed ID: 15518735
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Risk factors of arterial hypertension after renal transplantation.
    Béji S; Abderrahim E; Kaaroud H; Jebali H; Ben Abdallah T; El Younsi F; Ben Moussa F; Ben Hamida F; Sfaxi A; Blah M; Chebil M; Ayed M; Bardi R; Gorgi Y; Kheder A
    Transplant Proc; 2007 Oct; 39(8):2580-2. PubMed ID: 17954181
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Living-unrelated (paid) renal transplantation--ten years later.
    Ivanovski N; Popov Z; Cakalaroski K; Masin J; Spasovski G; Zafirovska K
    Transplant Proc; 2005 Mar; 37(2):563-4. PubMed ID: 15848457
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Surgical complications in live-donor pediatric and adolescent renal transplantation: study of risk factors.
    Shokeir AA; Osman Y; Ali-El-Dein B; El-Husseini A; El-Mekresh M; Shehab-El-Din AB
    Pediatr Transplant; 2005 Feb; 9(1):33-8. PubMed ID: 15667608
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Membranous glomerulonephritis (MGN) in transplanted kidneys: morphologic investigation on 256 renal allografts.
    Monga G; Mazzucco G; Basolo B; Quaranta S; Motta M; Segoloni G; Amoroso A
    Mod Pathol; 1993 May; 6(3):249-58. PubMed ID: 8346172
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Allogeneic bone marrow transplantation for acute myeloblastic leukaemia in remission: risk factors for long-term morbidity and mortality.
    Robin M; Guardiola P; Dombret H; Baruchel A; Esperou H; Ribaud P; Devergie A; Gluckman E; Socié G
    Bone Marrow Transplant; 2003 May; 31(10):877-87. PubMed ID: 12748664
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lessons learned from ABO-incompatible living donor kidney transplantation: 20 years later.
    Squifflet JP; De Meyer M; Malaise J; Latinne D; Pirson Y; Alexandre GP
    Exp Clin Transplant; 2004 Jun; 2(1):208-13. PubMed ID: 15859930
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Latent IgA deposition from donor kidney is the major risk factor for recurrent IgA nephropathy in renal transplantation.
    Moriyama T; Nitta K; Suzuki K; Honda K; Horita S; Uchida K; Yumura W; Tanabe K; Toma H; Nihei H; Yamaguchi Y
    Clin Transplant; 2005; 19 Suppl 14():41-8. PubMed ID: 15955168
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evolution of hepatitis C virus quasispecies in renal transplant patients with de novo glomerulonephritis.
    Kamar N; Rostaing L; Boulestin A; Sandres K; Dubois M; Ribes D; Modesto A; Durand D; Izopet J
    J Med Virol; 2003 Apr; 69(4):482-8. PubMed ID: 12601755
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Transplantation: impact of pretransplant renal insufficiency.
    Bahirwani R; Campbell MS; Siropaides T; Markmann J; Olthoff K; Shaked A; Bloom RD; Reddy KR
    Liver Transpl; 2008 May; 14(5):665-71. PubMed ID: 18433034
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Thirty years of renal transplantation in Helsinki.
    Salmela K; Kyllönen L; Eklund B; Isoniemi H; Holmberg C; Koskimies S; Höckerstedt K; Mäkisalo H; Leijala M; Ahonen J
    Clin Transpl; 1994; ():219-28. PubMed ID: 7547543
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Kidney transplantation in the United States.
    Cecka JM
    Clin Transpl; 2008; ():1-18. PubMed ID: 19711510
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Surgical management of epithelial parotid tumours.
    Obaid MA; Yusuf A
    J Coll Physicians Surg Pak; 2004 Jul; 14(7):394-9. PubMed ID: 15279739
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mycobacterial infections after kidney transplant.
    Jie T; Matas AJ; Gillingham KJ; Sutherland DE; Dunn DL; Humar A
    Transplant Proc; 2005 Mar; 37(2):937-9. PubMed ID: 15848580
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Is an elderly recipient a risk for living donor adult liver transplantation?
    Suehiro T; Shimada M; Kishikawa K; Shimura T; Soejima Y; Yoshizumi T; Hashimoto K; Mochida Y; Maehara Y; Kuwano H
    Hepatogastroenterology; 2008; 55(82-83):653-6. PubMed ID: 18613426
    [TBL] [Abstract][Full Text] [Related]  

  • 40. De novo solid malignancies after cardiac transplantation.
    Goldstein DJ; Williams DL; Oz MC; Weinberg AD; Rose EA; Michler RE
    Ann Thorac Surg; 1995 Dec; 60(6):1783-9. PubMed ID: 8787481
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.